+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sweden Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update

  • PDF Icon

    Report

  • 50 Pages
  • March 2025
  • Region: Sweden
  • BioIntel360
  • ID: 6067413
Description Jump to:
The diabetes market in Sweden is expected to grow by 12.3% on annual basis to reach US$1.04 billion in 2025.

The diabetes market in the country has experienced robust growth during 2020-2024, achieving a CAGR of 13.2%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 10.1% during 2025-2029. By the end of 2029, the diabetes market is projected to expand from its 2024 value of USD 934.1 million to approximately USD 1.72 billion.

This report provides a detailed data-centric analysis of the diabetes industry in Sweden, covering market opportunities and analysis across a range of diagnosis and monitoring devices, therapeutics, domains. With over 50+ KPIs at the country level, this report provides a comprehensive understanding of diabetes market dynamics, market size and forecast, and market share statistics.

It breaks down market opportunities by industries, deployment models, and enterprise sizes. In addition, it provides a snapshot across combination drugs, route of administration. The report also segments the market by type of diabetes, distribution channels, offering insights into end user trends. KPIs in value terms help in gaining an in-depth understanding of end-market dynamics.

The research methodology is based on industry best practices. Its unbiased analysis leverages a proprietary analytics platform to offer a detailed view of emerging business and investment market opportunities.ScopeThis report provides an in-depth, data-centric analysis of the Latin America diabetes devices and therapeutics market 2020-2029. Below is a summary of key market segments:

Diabetes Devices and Therapeutics Market Share by Category

  • Diagnosis and Monitoring Devices
  • Therapeutics

Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices

  • Blood Glucose Monitoring Devices
  • Insulin Delivery Devices
  • Diabetes Management and Mobile Applications
  • Artificial Pancreas Devices

Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices

  • Self-Monitoring Blood Glucose Devices
  • Continuous Blood Glucose Monitoring Devices
  • Test Strips
  • Lancets

Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices

  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes

Diabetes Devices and Therapeutics Market Share by Therapeutics

  • Oral Anti-Diabetic Drugs
  • Insulin
  • Non-Insulin Injectable Drugs
  • Combination Drugs

Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs

  • Alpha-Glucosidase Inhibitors
  • DPP-4 Inhibitors
  • SGLT-2 Inhibitors

Diabetes Devices and Therapeutics Market Share by Insulin

  • Basal or Long-Acting
  • Bolus or Fast-Acting
  • Traditional Human Insulin Drugs
  • Insulin Biosimilars

Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs

  • GLP-1 Receptor Agonists
  • Amylin Analogue

Diabetes Devices and Therapeutics Market Share by Combination Drugs

  • Combination Insulin
  • Oral Combination

Diabetes Devices and Therapeutics Market Share by Route of Administration

  • Subcutaneous
  • Intravenous
  • Others

Diabetes Devices and Therapeutics Market Share by Type of Diabetes

  • Type 1 Diabetes
  • Type 2 Diabetes

Diabetes Devices and Therapeutics Market Share by Distribution Channels

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies

Diabetes Devices and Therapeutics Market Share by End User

  • Hospitals
  • Diabetes Clinics
  • Homecare

Reasons to buy

  • Comprehensive understanding of market structure and dynamics: Gain a detailed view of the diabetes devices and therapeutics market, including category-level segmentation (Diagnosis & Monitoring Devices and Therapeutics) and sub-segmentation by product type, route of administration, type of diabetes, distribution channel, and end user.
  • Identify high-growth segments and strategic investment areas: Use segment-wise market sizing and forecasting to identify opportunities in areas such as continuous glucose monitoring, insulin delivery technologies, oral anti-diabetic drugs, and biosimilars. Tailor your market entry or expansion strategies accordingly.
  • Benchmark performance across distribution and care settings: Access share analysis across online, hospital, and retail pharmacies, and evaluate usage patterns across hospitals, diabetes clinics, and homecare to support channel-specific planning and resource allocation.

Table of Contents

1 Sweden Diabetes Devices and Therapeutics Market Size and Forecast, 2020-2029
2 Sweden Diabetes Devices and Therapeutics Market Share by Category, 2020-2029
2.1 Sweden Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2020-2029
2.2 Sweden Diabetes Devices and Therapeutics Market Size by Therapeutics, 2020-2029
3 Sweden Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2020-2029
3.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2020-2029
3.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2020-2029
3.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2020-2029
3.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2020-2029
4 Sweden Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2020-2029
4.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2020-2029
4.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2020-2029
4.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2020-2029
4.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2020-2029
5 Sweden Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2020-2029
5.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2020-2029
5.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2020-2029
5.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2020-2029
6 Sweden Diabetes Devices and Therapeutics Market Share by Therapeutics, 2020-2029
6.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2020-2029
6.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2020-2029
6.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2020-2029
6.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2020-2029
7 Sweden Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2020-2029
7.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2020-2029
7.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2020-2029
7.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2020-2029
8 Sweden Diabetes Devices and Therapeutics Market Share by Insulin, 2020-2029
8.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2020-2029
8.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2020-2029
8.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2020-2029
8.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2020-2029
9 Sweden Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2020-2029
9.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2020-2029
9.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2020-2029
10 Sweden Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2020-2029
10.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2020-2029
10.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2020-2029
11 Sweden Diabetes Devices and Therapeutics Market Share by Route of Administration, 2020-2029
11.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2020-2029
11.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2020-2029
11.3 Diabetes Devices and Therapeutics Market Size by Others, 2020-2029
12 Sweden Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2020-2029
12.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2020-2029
12.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2020-2029
13 Sweden Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2020-2029
13.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2020-2029
13.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2020-2029
13.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2020-2029
14 Sweden Diabetes Devices and Therapeutics Market Share by End User, 2020-2029
14.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2020-2029
14.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2020-2029
14.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2020-2029
List of Tables
Table 1: Sweden Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Table 2: Sweden Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Table 3: Sweden Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Table 4: Sweden Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 5: Sweden Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Table 6: Sweden Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Table 7: Sweden Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Table 8: Sweden Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Table 9: Sweden Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 10: Sweden Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Table 11: Sweden Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Table 12: Sweden Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (US$ Million) 2020-2029
Table 13: Sweden Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (US$ Million) 2020-2029
Table 14: Sweden Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (US$ Million) 2020-2029
Table 15: Sweden Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Table 16: Sweden Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Table 17: Sweden Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Table 18: Sweden Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Table 19: Sweden Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Table 20: Sweden Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Table 21: Sweden Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Table 22: Sweden Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Table 23: Sweden Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Table 24: Sweden Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Table 25: Sweden Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Table 26: Sweden Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Table 27: Sweden Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Table 28: Sweden Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Table 29: Sweden Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Table 30: Sweden Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Table 31: Sweden Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Table 32: Sweden Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Table 33: Sweden Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Table 34: Sweden Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Table 35: Sweden Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Table 36: Sweden Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Table 37: Sweden Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Table 38: Sweden Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Table 39: Sweden Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Table 40: Sweden Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
List of Figures
Figure 1: Sweden Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Figure 2: Sweden Diabetes Devices and Therapeutics Market Share by Category (%), 2020-2029
Figure 3: Sweden Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Figure 4: Sweden Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Figure 5: Sweden Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2020-2029
Figure 6: Sweden Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 7: Sweden Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Figure 8: Sweden Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Figure 9: Sweden Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Figure 10: Sweden Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2020-2029
Figure 11: Sweden Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Figure 12: Sweden Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 13: Sweden Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Figure 14: Sweden Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Figure 15: Sweden Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2020-2029
Figure 16: Sweden Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (US$ Million) 2020-2029
Figure 17: Sweden Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (US$ Million) 2020-2029
Figure 18: Sweden Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (US$ Million) 2020-2029
Figure 19: Sweden Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2020-2029
Figure 20: Sweden Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Figure 21: Sweden Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Figure 22: Sweden Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Figure 23: Sweden Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Figure 24: Sweden Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2020-2029
Figure 25: Sweden Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Figure 26: Sweden Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Figure 27: Sweden Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Figure 28: Sweden Diabetes Devices and Therapeutics Market Share by Insulin (%), 2020-2029
Figure 29: Sweden Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Figure 30: Sweden Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Figure 31: Sweden Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Figure 32: Sweden Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Figure 33: Sweden Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2020-2029
Figure 34: Sweden Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Figure 35: Sweden Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Figure 36: Sweden Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2020-2029
Figure 37: Sweden Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Figure 38: Sweden Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Figure 39: Sweden Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2020-2029
Figure 40: Sweden Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Figure 41: Sweden Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Figure 42: Sweden Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Figure 43: Sweden Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2020-2029
Figure 44: Sweden Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Figure 45: Sweden Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Figure 46: Sweden Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2020-2029
Figure 47: Sweden Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Figure 48: Sweden Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Figure 49: Sweden Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Figure 50: Sweden Diabetes Devices and Therapeutics Market Share by End User (%), 2020-2029
Figure 51: Sweden Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Figure 52: Sweden Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Figure 53: Sweden Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029

Table Information

Report AttributeDetails
No. of Pages50
PublishedMarch 2025
Forecast Period2025 - 2029
Estimated Market Value ( USD ) in 2025 $ 1.17 Billion
Forecasted Market Value ( USD ) by 2029 $ 1.72 Billion
Compound Annual Growth Rate10.1%
Regions CoveredSweden

Related Topics

Related Reports

Diabetes Devices Market Size, Share & Trends Analysis Report by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Diabetes Devices Market Size, Share & Trends Analysis Report by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 195 Pages
  • Global
From
Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update - Product Image

Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update

  • Report
  • 1400 Pages
  • Global
From
Europe Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update - Product Image

Europe Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update

  • Report
  • 980 Pages
  • Europe
From
Diabetes Insulin Pumps Market - Global Forecast 2025-2030 - Product Image

Diabetes Insulin Pumps Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Medical Insulin Pumps Market - Global Forecast 2025-2030 - Product Image

Medical Insulin Pumps Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.